{"version":"1.0","type":"link","title":"PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy.","author_name":"Lou H 외","author_url":"https://prs-insight.online/author/Lou%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166665","thumbnail_width":1200,"thumbnail_height":630}